STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13G/A] InspireMD, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Rosalind Advisors and affiliated funds report shared beneficial ownership in InspireMD (NSPR), including common shares and warrants that together total 10,987,104 securities representing 9.4% of the class as stated on the cover page. The holding is shown as 3,905,743 common shares plus 7,081,361 shares issuable on warrants for the Advisor group, while Rosalind Master Fund L.P. reports 3,508,336 common and 5,977,361 warrant-issuable shares, and Rosalind Opportunities Fund I L.P. reports 397,407 common and 1,104,000 warrant-issuable shares. The filing notes that blocker provisions limit exercise of some warrants, so the actual exercisable ownership is lower than the raw totals. The Advisor and certain principals disclaim beneficial ownership of shares held by advised funds.

Positive

  • Significant institutional interest: Reporting persons disclose a 9.4% economic position, indicating notable investor commitment to NSPR.
  • Clear disclosure of warrant exposure: The filing separates common shares from warrant-issuable shares, improving transparency about potential dilution.

Negative

  • Exercisability limited by blockers: Warrant exercise is restricted to prevent ownership above 9.99%, so reported totals overstate immediate control or voting power.
  • Potential ambiguity in outstanding-share bases: The filing references different outstanding-share counts for percentage calculations, which may cause confusion about exact ownership percentages.

Insights

TL;DR: A passive investor group reports a near-10% economic position in NSPR largely via warrants; blockers limit immediate dilution and voting impact.

The Schedule 13G/A shows Rosalind Advisors and affiliated funds/individuals holding a combined reported position of 10,987,104 securities (3.9M common + 7.08M warrant-issuable). Material here is the split between currently outstanding common shares and shares tied to warrants plus the explicit blocker provisions that prevent exercise beyond ownership thresholds. For investors, this means disclosed economic exposure is significant but immediate voting and control effects are constrained by the blockers and the filing language that indicates passive intent.

TL;DR: Reporting shows substantial stake concentration, but governance influence appears limited by blocker clauses and the Advisor's disclaimer of direct beneficial ownership.

The filing names Rosalind Advisors, Rosalind Master Fund L.P., Rosalind Opportunities Fund I L.P., and two named individuals as reporting persons with shared voting/dispositive power over reported positions. The presence of shared power and the Advisor-client relationships are disclosed, and the Advisor disclaims beneficial ownership of fund holdings. From a governance perspective, the combination of shared power and warrant-based exposure merits monitoring, but the blocker provisions and the 13G-style filing language indicate the group does not currently assert control intent.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth in Row 11 of the cover page for each Reporting Person is based upon 41,720,662 shares of common stock outstanding of the Issuer as of August 1, 2025, in accordance with the S-3 filed on August 1st. However, as more fully described in Item 4, the securities reported in rows 6, 8, and 9 show the number of shares of Common Stock that would be issuable upon exercise of such reported securities and do not give effect to blocker provisions. Therefore, the actual number of shares of Common Stock beneficially owned by such Reporting Person, after giving effect to such blockers, is less than the number of securities reported in rows 6, 8, and 9. (6) 3,905,743 shares of Common Stock 7,081,361 shares of Common Stock issuable upon exercise of warrants


SCHEDULE 13G




Comment for Type of Reporting Person: (6)3,905,743 shares of Common Stock 7,081,361 shares of Common Stock issuable upon exercise of warrants


SCHEDULE 13G




Comment for Type of Reporting Person: (6)3,905,743 shares of Common Stock 7,081,361 shares of Common Stock issuable upon exercise of warrants


SCHEDULE 13G




Comment for Type of Reporting Person: (6)3,508,336 shares of Common Stock 5,977,361 shares of Common Stock issuable upon exercise of warrants


SCHEDULE 13G




Comment for Type of Reporting Person: (6)397,407 shares of Common Stock 1,104,000 shares of Common Stock issuable upon exercise of warrants


SCHEDULE 13G



Rosalind Advisors, Inc.
Signature:Steven Salamon
Name/Title:President
Date:08/11/2025
SALAMON STEVEN A J
Signature:Steven Salamon
Name/Title:Steven Salamon
Date:08/11/2025
Aharon Gil
Signature:Gil Aharon
Name/Title:Gil Aharon
Date:08/11/2025
Rosalind Master Fund L.P.
Signature:Mike McDonald
Name/Title:Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund)
Date:08/11/2025
Rosalind Opportunities Fund I L.P.
Signature:Steven Salamon
Name/Title:Director, Rosalind Opportunities Fund I GP. Inc. (as General Partners to Rosalind Opportunities Fund I)
Date:08/11/2025

FAQ

What stake does Rosalind Advisors report in InspireMD (NSPR)?

Rosalind Advisors and affiliated reporting persons disclose an aggregate of 10,987,104 securities representing 9.4% of the class as stated on the cover page.

How many common shares and warrants are included in the reported position?

The group reports 3,905,743 common shares plus 7,081,361 shares issuable upon exercise of warrants for the Advisor group (other funds have similar breakdowns).

Do the warrants give the holder immediate voting power?

No. The filing discloses blocker provisions that prevent exercise to the extent doing so would push beneficial ownership above certain thresholds, limiting immediate voting impact.

Which entities and individuals are named as reporting persons?

The filing lists Rosalind Advisors, Inc., Rosalind Master Fund L.P., Rosalind Opportunities Fund I L.P., and individuals Steven Salamon and Gilad Aharon as reporting persons.

Does the Advisor claim direct beneficial ownership of fund holdings?

The Advisor and Mr. Salamon state they disclaim beneficial ownership of the shares held by the advised funds.
Inspiremd

NASDAQ:NSPR

NSPR Rankings

NSPR Latest News

NSPR Latest SEC Filings

NSPR Stock Data

84.74M
33.05M
22.45%
40.55%
0.31%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
MIAMI